Contact Us

MEETING NEWS

Akeso Announces the Completion of Patient Enrollment in the Phase III Clinical Trial (HARMONi-6) Comparing Ivonescimab and Tislelizumab for First-Line Treatment of Sq-NSCLC

Feb 7, 2025

HONG KONG,Feb. 6,2025--Akeso,Inc. (9926.HK) ("Akeso" or the "Company")is excited to announce the completion of patient enrollment in the global Phase III clinical trial (HARMONi-6/

SunCar Technology Group Announces Pricing of $50 Million Follow-On Public Offering of Class A Ordinary Shares

Feb 7, 2025

NEW YORK,Feb. 6,2025-- SunCar Technology Group Inc. ("SunCar") (Nasdaq: SDA),an innovative leader in cloud-based B2B auto services and auto e-insurance in China,today announced the pricing o

Channel Factory partners with Dentsu Japan International Brands to drive unmatched media efficiency for YouTube campaign

Feb 7, 2025

SINGAPORE,Feb. 5,2025--Dentsu Japan International Brands Inc. (DJIB),the leading agency in the Japanese advertising market,has partnered with Channel Factory,a specialist in contextual targeting and m

Amadeus and Traveloka strengthen travel technology partnership

Feb 7, 2025

SINGAPORE,Feb. 6,2025-- Amadeus,the leading global travel technology company,has strengthened its partnership with Traveloka,Southeast Asia\'s top travel platform. This agreement sees Amadeus\' alread

Argent BioPharma: A Hidden Gem traded Under $12M--Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment

Feb 7, 2025

PERTH,Australia,Feb. 6,2025-- Argent BioPharma (ASX: RGT) (OTCQB: RGTLF),a clinical-stage biopharmaceutical company brings hope to epilepsy patients.

St. Luke's Medical Center Achieves GHA Accreditation for Medical Travel Services

Feb 7, 2025

PALM BEACH GARDENS,Fla.,Feb. 6,2025--St. Luke\'s Medical Centerhas achieved another significant milestone,becoming the first and only hospital in the Philippines to receive accreditation from the este

1 ... 98 99 100 101 102 103 104 ... 348